Ophthalmology Drugs
309 FDA-approved drugs
TheraRadar tracks 309 FDA-approved ophthalmology drugs from 89 companies across 20 drug classes, led by Novartis, with 271 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Ophthalmology.
Ophthalmology Approvals by Year
'15
7
'16
5
'17
5
'18
5
'19
7
'20
5
'21
5
'22
12
'23
5
'24
6
'25
1
'26
Recent Ophthalmology Drug Approvals
YUVEZZI
BRIMONIDINE TARTRATE
presbyopia in adults...
2026-01-28
VISUS
NUFYMCO
RANIBIZUMAB-LEYK
2025-12-18
FORMYCON AG
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE
ster...
2025-12-10
ALEMBIC
ZOLYMBUS
BIMATOPROST
the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular ...
2025-09-09
THEA PHARMA
VIZZ
ACECLIDINE HYDROCHLORIDE
presbyopia in adults...
2025-07-31
LENZ THERAP
TRYPTYR
ACOLTREMON
the signs and symptoms of dry eye disease...
2025-05-28
Novartis
LATANOPROSTENE BUNOD
LATANOPROSTENE BUNOD
the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertens...
2025-04-29
GLAND
ENZEEVU
AFLIBERCEPT-ABZV
2024-08-09
Novartis
YESAFILI
AFLIBERCEPT-JBVF
2024-05-20
BIOCON BIOLOGICS INC
OPUVIZ
AFLIBERCEPT-YSZY
2024-05-20
SAMSUNG BIOEPIS CO LTD
LUMIFY PRESERVATIVE FREE
BRIMONIDINE TARTRATE
2024-04-19
BAUSCH AND LOMB INC
FLUOROMETHOLONE
FLUOROMETHOLONE
corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior ...
2024-01-09
AMNEAL
IDOSE TR
TRAVOPROST
the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hyp...
2023-12-13
GLAUKOS
QLOSI
PILOCARPINE HYDROCHLORIDE
presbyopia in adults...
2023-10-17
ORASIS PHARMS
FLUORESCEIN SODIUM
FLUORESCEIN SODIUM
INDICATIONS For testing tear film stability by determining the fluorescein break-up time (FBUT)...
2023-09-25
BPI LABS
RYZUMVI
PHENTOLAMINE MESYLATE
pharmacologically-induced mydriasis produced by adrenergic agonists (e...
2023-09-25
FAMYGEN LIFE SCI
LIFITEGRAST
LIFITEGRAST
2023-08-04
MICRO LABS
IZERVAY
AVACINCAPTAD PEGOL SODIUM
geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...
2023-08-04
ASTELLAS
XDEMVY
LOTILANER
Demodex blepharitis...
2023-07-24
TARSUS
ALCAFTADINE
ALCAFTADINE
2023-06-23
GLAND
Showing the 20 most recent of 309 ophthalmology drugs. View all 309 →
Top Ophthalmology Companies
Ophthalmology Active Trials by Indication
271 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Ophthalmology Drug Classes
Prostaglandin Analog 12
Corticosteroid 12
Calcineurin Inhibitor Immunosuppressant 5
Aminoglycoside Antibacterial 3
Vascular Endothelial Growth Factor Inhibitor 3
Carbonic Anhydrase Inhibitor 3
Quinolone Antimicrobial 3
Anticholinergic 2
Ectoparasiticide 1
Semifluorinated Alkane 1
Ophthalmology at a Glance
- Total Drugs
- 309
- Companies
- 89
- Drug Classes
- 20
- Active Trials
- 271
- Latest Approval
- 2026-01-28